Four years of shortage and waiting lists More production to respond to global demand The arrival of new treatments reduces pressure New presentations by Ozempic The combination of a greater production by Novo Nordisk, the arrival of new competitors and the appearance of presentations with more doses has allowed progressively normalizing the supply in pharmacies.According to data from the digital network of pharmacies LUDA Partners provided to Co…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Four years of shortage and waiting lists More production to respond to global demand The arrival of new treatments reduces pressure New presentations by Ozempic The combination of a greater production by Novo Nordisk, the arrival of new competitors and the appearance of presentations with more doses has allowed progressively normalizing the supply in pharmacies.According to data from the digital network of pharmacies LUDA Partners provided to Co…